Skip to content

First-in-Man Study on the Stentys

First-in-Man Study on the Stentys - Stentys Open I

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35517
Enrollment
20
Registered
2007-12-12
Start date
2008-01-21
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bifurcation

Interventions

The Stentys stent is developed to treat bifurcation lesions. The Stentys stent itself will be places in the main branch and a standard workhorse stent will be used in the side branch if required.

Sponsors

Stentys SAS
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients from 18-85 years of age. Patients with symptomatic ischemic heart disease and/or objective evidence of myocardial ischemia. Side branch angle from 30 to 70 degrees Main vessel target lesion is located in a native coronary artery. Main vessel diameter 3.0 to 4.5 mm.

Exclusion criteria

Exclusion criteria: Totally occluded vessel Patient not candidated for CABG Left main coronary disease Patient is diabetic Evidence of thrombus Patient pregnant

Design outcomes

Primary

MeasureTime frame
Composite Endpoint - 'Procedural Success' - Successful deployment of the Stenty stent and creation of side branch opening verified using IVUS - Angiographic Success:

Secondary

MeasureTime frame
Clinical Parameters: - non-Mace, Serious Adverse Events (SAE) at hospital discharge - MACE and Anginal Status at post procedure and up to 48 months. Angiographic Parameters - Acute IVUS Success - Angiographic restenosis at 6 months and 2 years - Volumetric Late Loss by Ivus and OCT to assess stent coverage at six months and 2 years without OCT - In-stent and vessel segment percentage DS (diameter stenosis) post-procedure.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)